0001104659-24-010051.txt : 20240202 0001104659-24-010051.hdr.sgml : 20240202 20240202162027 ACCESSION NUMBER: 0001104659-24-010051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240201 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 24591753 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 8-K 1 tm244922d1_8k.htm FORM 8-K
false 0000882095 CA 0000882095 2024-02-01 2024-02-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): FEBRUARY 1, 2024

 

 

 

GILEAD SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 0-19731 94-3047598
(State or other jurisdiction
of incorporation)		 (Commission File No.) (IRS Employer
Identification No.)

 

333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA

(Address of principal executive offices)

 

94404

(Zip Code)

 

(650) 574-3000

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s)

Name of each exchange on which
registered

Common Stock, par value, $0.001 per share GILD The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

(d)Appointment of a Director.

 

On February 1, 2024, at a meeting of the Board of Directors (the “Board”) of Gilead Sciences, Inc. (the “Company”), the Board increased the size of the Board from nine directors to ten directors and elected Ted W. Love, M.D., to serve on the Board, effective immediately after the close of such meeting. The Board also selected Dr. Love to serve on the Audit Committee of the Board, effective immediately upon the conclusion of the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”), subject to his re-election as a director by the Company’s stockholders at such meeting. There is no arrangement or understanding between Dr. Love and any other persons pursuant to which Dr. Love was selected as a director, and there are no related party transactions involving Dr. Love that are reportable under Item 404(a) of Regulation S-K.

 

Dr. Love will participate in and receive compensation for his service on the Board for the remainder of the 2023-2024 service period in accordance with the Company’s standard non-employee director compensation programs, including grants to be made under the Company’s 2022 Equity Incentive Plan (the “Plan”).

 

A description of the Plan and compensation practices for non-employee directors can be found in our Definitive Proxy Statement filed with the Securities and Exchange Commission (SEC) on March 23, 2023 in connection with the Company’s 2023 Annual Meeting of Stockholders. The Plan is attached as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on May 5, 2022.

 

A copy of the Company’s press release announcing Dr. Love’s election to the Board is attached as Exhibit 99.1 to this report.

 

Item 9.01 Financial Statements and Exhibits

 

(d)Exhibits

 

The following exhibit 99.1 is furnished pursuant to this Item 9.01.

 

Exhibit

Number

   Description
99.1   Press Release by Gilead Sciences, Inc. dated February 1, 2024.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GILEAD SCIENCES, INC.
  (Registrant)
   
   
  /s/ Deborah H. Telman
  Deborah H. Telman
 

EVP, Corporate Affairs, General Counsel

and Corporate Secretary

 

Date:February 2, 2024

 

 

 EX-99.1 2 tm244922d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

  Gilead Contacts:
   
  Jacquie Ross, Investors
  investor_relations@gilead.com
   
  Ashleigh Koss, Media
  public_affairs@gilead.com

 

TED LOVE, MD, JOINS GILEAD SCIENCES’ BOARD OF DIRECTORS

 

FOSTER CITY, Calif., Feb. 1, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Ted Love, MD, has been appointed to the company’s Board of Directors.

 

Dr. Love is currently chair of the Board of Directors of the Biotechnology Innovation Organization and serves on the Boards of Directors of Royalty Pharma and Structure Therapeutics. Previously, he was the President and Chief Executive Officer of Global Blood Therapeutics, Inc. where he led the company from a pre-clinical startup to a global commercial company with a focus on sickle cell disease. Prior, he was Executive Vice President, Research and Development and Technical Operations at Onyx Pharmaceuticals, Inc.; President, Chief Executive Officer and Chairman of Nuvelo, Inc.; and Senior Vice President, Development at Theravance Biopharma, Inc. He began his biotech career at Genentech. Dr. Love earned his MD from the Yale School of Medicine and completed a residency in Internal Medicine and a fellowship in cardiology at Massachusetts General Hospital.

 

Known for championing access to care, Dr. Love received the William E. Proudford Sickle Cell Fund 2023 Distinguished Service Award for addressing ongoing healthcare disparities facing the sickle cell disease community. In 2023, he also earned the Spirit of the Heart Health Equity Champion Award from the Association of Black Cardiologists.

 

“We are delighted to welcome Ted Love to the Gilead Board of Directors,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences. “Ted is a highly respected executive leader with decades of experience in the biopharma industry, most recently as CEO of a global healthcare company. Ted also has a strong scientific background, and his focus on access and inclusion aligns perfectly with Gilead’s values. Ted will be a valuable addition to the Gilead Board as we continue to expand our impact on patients and communities worldwide.”

 

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

 

###

 

Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 USA
phone 650 574 3000 facsimile 650 578 9264		 www.gilead.com

 

For more information about Gilead, please visit the company’s website at  www.gilead.com  or follow Gilead on X (@GileadSciences).

 

 

 

 EX-101.SCH 3 gild-20240201.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 gild-20240201_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 gild-20240201_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm244922d1_ex99-1img001.jpg GRAPHIC begin 644 tm244922d1_ex99-1img001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#WV26.&,R2 MNJ(.K,< ?C4":A92MMCN[=V]%D!_K5;75#::JL 0;FW!![_ODKDOB3XI?0=. MBTS3F\F[NE)+IP8X^F1Z$GC/L:ENQUX?#.O*,([O]#H-=\9Z'X>8QWEWNN,9 M\B$;W_'L/Q(J;1-E%-M]%;HD=711T&37&CQK>:K>S6_AK1GU&.!MLEU)*(H\^Q/7_/ M%:'CG945C:+J&MW<\T6K:.EB$4%)$N!(),]L#I4.E^)#J/B?5='-J(Q8!2)= M^=^?;''YT ;]%8&C^)#JOB'5]+-J(AI[*HDWYWYSVQQTJ[X@U4Z)H5WJ0A\X MVZAO++;=W('7!]: -*BN,M/$_BJ_LX;NV\(H\$R!XV_M&,94\@X(S78NZQHS MN0JJ,DGL* '45R/A+QS%XHO[NU^R&V,2^9"2^[S4S@GH,8X]>OM6YK-QJMO; MQMI-C%>2E\.DLOE@+CKGZT :5%<9=^*/$VDQ&YU'PN&M5Y=[6Z#E!ZXQ73:3 MJEKK.F0:A9L6@F7*Y&".Q!]P>* +M%%% !1110!G:W_R#D_Z^K?_ -')7GWQ M1\,7U_J=CJ=HAD1PEHX'\#%SM)]B6Q_^NO2KZSCO[*:UE+!)5VEE.&7T(/8@ M\BLN&$O#,4I/;U-><^"]8;7_BE>:D5*K+ ^Q3U5!M"C\@* MYOQ]/<3>-=1MS++(BS )&6) ^4=!7HOPU\(S:%92ZC?Q>7?7(VJAZQQ]<'W) MP<>PJ+MRLNAZDJ%/"X2=:I*\ZBT^>O\ P[.NUJ*:XT+4(;;/GR6TBQXZ[BI M_6N7^%MW:R^$([6(J+FWD<3I_%DL2"?PP/P]J[:N;U+P-HNHWK7HCFM+IOOR MVDIC+?4#C]*U/FQ+;Q!=S?$&[T%DA^R0V@F5@IW[OEZG.,?,>U9/AG_DIGBC MZ1_TK=T7PCI>A7LE[;"XDNY$\MIIYB[%<@X].PJU9:#96&LWNJP^9]IO,>;N M;*\>@[4P.7\(_P#)0/%O_71/YM6SX]_Y$?5?^N0_]"%07OP_T>^U*YOWEO8Y M[AM\GE3[03^57(?".G0Z#=:/YEU):W+;I#)+N?MT/;[HH YKPWX<\0S:'IES M#XLEAMFAC=;<6P(5< [<[O3C-:_Q"U9[#PVUG;AFO-1;[+"J]3N^]^G'U(J) M?AMHR*%2ZU-5 P +H@#]*VKGPW87FH:;>3F9Y-.&(%+_ "@^I'<\#\A0!YO? M2ZGH%[X?U67P_+IMMIP6UED\]9/,0]AY<_4UUOC[5[S3;'29=/NFB\^\1 M&9,?,A!XKIM4TRVUC39]/O%+03## '!ZY!'OD5F:EX1T[5='L],NI;HPV9!B M<2 /P,#)QSQ0!JZA?VFFV,MW?2I%;HN69SP?;W)]*Y?X8P2P^$?,="D<]S)+ M"A[(< ?J#5B'X>Z&LJR77VN^*G*K=W#.H/TX_6NHCC2*-8XT5$4 *JC ] * M0#J*** "BBB@ JM>6%O?QJEQ'DH=R.I*NA]58<@_2K-% TVG=&%8^$=*LM4E MU1XWNK^1MWVBX(9E[# 'UQGWK=HHI)6+G4G4=YNX4444S,**** .;:^'_" M1W$%[J4]JZRQBUMT&%E4@<]#NR<@^F.U5KOQ5?VL%O(;2 ^>\FP[B 0AP%R? MXCS_ (&NLP"0<*JZ?X@ MOI-,BN':.:X>WA/S<)N>9HSD#H1@?E778&?4?6M'Q#)??:["WL7F#RB7Y8G"9(48))[ UIWFF6M^R& MY1V"C&T2LJD>A .#^-7* .8M_$-XNH-8SQ0/+$&1T!(DRL>[S#Q@(3Q^(^E, MMO%4\R:6S108NYFB M65VDGFQNAM2_D3,:=YF(1)ONI5#3-M5 H4A/JJGTHI]% '_]D! end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Feb. 01, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 01, 2024
Entity File Number 0-19731
Entity Registrant Name GILEAD SCIENCES, INC.
Entity Central Index Key 0000882095
Entity Tax Identification Number 94-3047598
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 333 LAKESIDE DRIVE
Entity Address, City or Town FOSTER CITY
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94404
City Area Code 650
Local Phone Number 574-3000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value, $0.001 per share
Trading Symbol GILD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://gilead.com/role/Cover Cover Cover 1 false false All Reports Book All Reports gild-20240201.xsd gild-20240201_lab.xml gild-20240201_pre.xml tm244922d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm244922d1_8k.htm": { "nsprefix": "GILD", "nsuri": "http://gilead.com/20240201", "dts": { "schema": { "local": [ "gild-20240201.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "gild-20240201_lab.xml" ] }, "presentationLink": { "local": [ "gild-20240201_pre.xml" ] }, "inline": { "local": [ "tm244922d1_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://gilead.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-02-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm244922d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-01", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm244922d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://gilead.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001104659-24-010051-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-010051-xbrl.zip M4$L#!!0 ( (R"0EC3^KKI*P, -T+ 1 9VEL9"TR,#(T,#(P,2YX M],_T'U:\8W:-*$0#(I&5(ZI&FA29.\=(0M$S6RY$IR@'Y] M)=OB9G"!MCQ)N^>X=HB'CM_WN3/=)RD0T7'<\'CN4O< QX\_" M"5B\G>! 0IF*F9HW\8K?=O1K+((9^0!>'([?3?KX?H3H<=J#]LKRAO7'<9';LWS?/?^NC?(<%8.;$P(IL_KX/[)R8F;>0VTA)P,.3'2=5>[ MAU"@F;+RX@H\ID)"&BSA0SDC+((/W=RY!,5KH409C,P!$4PTRT<"R!!9=EH#*N@FPY39!8"\U=2X2K;N]RAAVIMH>A M[DB->>O5/%_-%4$QHK+#>'R)(I@2E<;/%!(<811:0$(^0E*WF$A@@"JU3)=" M2IEJ9C51A47;D@2K;IT9E$G?;H,S@KZJM(%>J&E:%T"[W#93[X$%<-BR\N6" ME!$+480IS@(7L^,#6T]*JDM4RXS9=%?!9:54H/"&GF7KA".AZ%E!/64H^ 6D MFAM $J1D+^H\ORIF83?'6#I?,T)]%(%L]!JZ25J6P/KQLPK;$T=1RU)''MKF M-K^KLAW51 :B(U2,7G9'JR=5!#82D RS(I"HH>F<;GJU-ME^SZ[XS$>$\TUV2F)_ ;DD8WAY);'C%U\47F^!ZH5NH MOFW0#5^#RJ!K.2XB4AC+WBDL?CO^(H=,9J["(//+T'_$=@W[!Y=4 Z^K@6:;JZF MEK\!4$L#!!0 ( (R"0EC]' +[_0H ("& 5 9VEL9"TR,#(T,#(P M,5]L86(N>&ULS9U=;^.X%8;O"_0_<-V;%AC'$P$"]WPB+N?AZ/Z_J?O)$1?K MR?3CQ^/)/W^Y7D2/9(/'"5/'+2(C':5JL<4=GYZ>3O)2+6TI=RM!]3Y.)MI. M5;,L33KT-2=I3//LOVS1"E-% FCT=$PN-+]C[79K0G^_*[([+_H0'U>.=- M6/(,TW>9KTRT\- MBV27R0F,Q-JDJJ)C!,[WD$\,9=U5[3QJU$O5:,Y%N^UJ9LSK3$ETM.8ODY@D MLN[IB?HP5A_R9LO__#'CDY&]/B,!;A#X)OK+LM6\TMA7_0515?'!:Y"\!H0R9(RKJ_WR:'&IQT-%R";3=$)8M98V6%C2+776S MS93NY7I9$)UL,63VL98@I7'>+H@K$MIO?DF8LN M?)HRU]383)JPU#5!,6(Q!J)1:%$A]D3$KUMYQDX$W?="T5*ZY@*P:J)AR(*B MP^X-!*22^V5D*3!+$S6 ]4+2ECH_W0#,MDX]#%U0G #FX%.22N^7E,4CH53= M#\"L?T"QB5W3 ALV>6DK@R(&M @,B0<;"Y?U.I<+I,&-K:F]PE/RW87 M/Y4X6(1,AP,IRL.0BO-$4NTV1 ]#+:5K>@"K)C>&+"AB[-Y 5@HYRO7^(;ED M\2!$*IT?0 R;=CQ*48!P-)WUH2'5/L&X2M((T\++E=R6=C3/HG4-"&C7A*0E M# H4R!T(2Q&@FNO#1.F]0#+;"M%P M#<\XL-393=D>L]7]64 7!"@]YEIW;0MY Q1/,] ERY)LKYZGN]EN5D18&M>6 MN&(#,J>9,,N#8 $P93)0R)#2H4+HI>?U70*6J8<8P>:8,K<$V$TV*6AJ B+! M:@R@X:#-GRGU0L1,CDP"TSF+R>YGL@?;U=*Y90*PV83"$ 5$A=T9@$4I1KD: M2;D7,.Y$LL%BOTBBGJFB+72+!F2TR8:I"@@.P!I 1ZE&B_G,YTRRQ+MY+$%- M'I+B>? >2D"]6UAZ;#>9 <0!H=/M$"!(!J%FE$^0YBSBXIG7'G>8\:T< / 5(U>"'N(H[E@4K+ M?ZX31H[!]ENU;NGJL-MDRB(,B"38'2#0G+RAJ2?^H3D9"LU)T-"QYJ9_'@KEOS5]G V MJ/2"3-NJ%9B#+#Q<6M[Z8%$!:CVC0GQBDB^L;L6=X"\)B^ E,R3W @Q@VDJ- MH0T/';O!/GZJ!;&.\SK6%(ORWB^)EOD999HF[4-,H0D/DJ:QWL&E4/M$XHZG M&:;_3IX[3\3M8B]X6 U;(6DHPT/%9J\/F"(&R2 ?)]8EKNJ&AO55,J//7(&/R#0EKCJ:!TR9O9[+4*[S=#5>99A( M[<-WK M[K2I>]PJ"J+WNYR9))1:U!0[QF+!:1(E6<+6O\B33Y%@6ZML(E= P 8U#6U% M$"B MDP.#D*DE8XAN!-$04AD1^0O :K$0N+VX<$ZVW>)74'1;UC# 2N#@*37 MG@F+#!A'M0A4A* \QB\V\S3=$O$F>"PAGA "S0,@M?0AX@29[(6J"/3)UH)$ M6SD_[H^GJV624=O)95OB;$X"S%4SDE$>!!N *9.%O SQ!W0\_>OJ;TA'.>[^ M&[X46"6/7>PW*TZ![%-6E2L(.BQJ#BR2(%" ?9DTW'!42E&A]9&=JF'6TARC MW!4 5ENZZQN%072ZS5'KR]_H:T]#_N4N>I2F"/!"@EWF>NBWF32'_[HF" 0Z MC+5.2DHITEH?+R0,*@0=8EQGM,Q3G*GT_&*3[_]*?K"T M$M YRVG99;-*:FD3!<%(E[-66LLBZ5Q-C)3:-1?;.,E(7)BY2AAF48)IE1[1 M=D6\/\09+0/-5^#TZ,-@:)C)%DY%F,YE6 4>4EVZOI1>/(#Q&Z'T9\9?V8+@ ME#,2%]=2;'>*NO5NGYCIL=U\: 80!X'3$(? HS,J:/RDHI .*Z^$>2'I&Z=; MEF&1OTLN;",3H'-+#F"S28PA"H@4NS. D$J,"K6?%[2+[!'5(JOXW2&P@9#< M\>O:G::-M[:MVH"8Z30(O<-=YOPXK(V+*$^O6&9$_5Y$\D*^X R7WL#V0G+7 M+U5VF3;?IK1I T*HTR#X_F05HU+%8,V4MY0Q8B:76FO>\92XH7*?.*9EL9T[ MII($A(?-5T<&&8&TU@L+BPVF]/,V31A)X8G(4+EEP6JQR4)#$A +-E\ "[D4 M::T7%BXW1*SE]/:3X*_98YF?%6P;H';+1J?E)B-6:4"L=/D#F-$AJ(C1*77] MP+,[)!0OLBS"+;5('6,#FC68:>E" @8RUZ*%DDA=;[GA&5IR]#4E*'LDZ++\ M&;IZ)OBB'E^_-!)%ZH6(8E7.8BQL"'6)G?_J"&BX]=LC+640(/7:@W^'I(I M.L0Q-;>285$_C\M-S#.R =]VZ ]Q1=!0\YJC/GT0- TT:3*5AS5/KO- I")] M9C.J)[>'EW@-D>.5L<6@L3"N*8)@!+0%+8OKOQ7@)W?>=D63Z(IR#%]E:6@< M9\QKVS.2Y1T$ 1'0=@6ER,N%*%=ZZ?_/F#V)[7,6[>\$CPA13UFEU6C5=_UM M8+1;9M[4I"9-@T(#XNPM?@$"#U6@6AT?:C.6SXMYZJ%QES/4&!@'A6]U"IWHIJE> M5NH9L;(*]+NJ!.6UV'Z_O+[I6GZ2F_4F^=<*IT1N^2]02P,$% @ C()" M6)#I1095!P T5< !4 !G:6QD+3(P,C0P,C Q7W!R92YX;6S-G%USVC@4 MAN]W9O^#E[TF!.A^)$VVD]#089HVV9"VNWO3$;8 362)D>0 _WXE&U,^+/GD MQB>Y2(AY]?$^DF4?2_+%NU7*HV>J-)/BLM4].6U%5,0R86)VV?HR;E^-!Z-1 M*]*&B(1P*>AE2\C6N[]^_BFR/Q>_M-O1D%&>G$?O9=P>B:E\&WTF*3V//E!! M%3%2O8V^$IZY(W+(.%710*8+3@VU7Q0%GT>_G?2Z)&JW ?E^I2*1ZLO#:)OO MW)B%/N]TELOEB9#/9"G5DSZ)90K+<&R(R?0VM]/5Z>:G2'[!F7@Z=[\F1-/( M\A+Z?*799*5<3QK8R)R9N]MIC(JW#_M4M9 MVQUJ=WOM?O=DI9-6"3\GJ"2G#W0:N;^V];:ESFR?((EKKH[[JC.0MCO:>N:) MYHI.+UM6DMB\>V].>Z=YSK_NBAEFG'334;I1V_6J++4EV8^%W+. M6-/X9":?.PEEEG6O[SXX"OV<@/WG>U[0U40;16)3YL3)A/(\_^]6BNZ!L$70R@E6ZPB+ZG.E9LX;C4 M@-U3 OGV4/E6>&L850-YO,'E7>4/"_'=&E*&*KR&DC\1 V+]APO8X1.+]J(C0S/&! M #]6 XG_CGKCX?&(A'P\IYR[\(T(4"^OT@.Q_X&)W>_S%8"_>7;7=WMI@;/? M20+$_^=KP7_D%JD%[JEB,K&7= 5@?R0&4C_#I.YQB,K[1B10VELI./[!AWU@ M#PGUD.F8\*)&0WM,AW%7R*'(46+.6INHV/^E1(&A[XBAR%'"T!J+#0,?9$KM M528XJOC54.0H 6B=R8:9WPC#S-H][_^Z#H$^DD))H\2807LHJ.\52XE: MCUEE"48BEFHA M=QX7#V1FS\?U0";!(;TF(;0Y4.+-%UA':92K)+&X].;/+1.T&VJ*2CEXC@BO M 0(V7PGVWLNP]^#84>+06INO!'O_9=C[<.PHL6BM34SL _OQ3CW*I6<&VBN& M(D>)16LL8@+/KS1WZE[)9U:LAZJC?I0"BAXQ1 V;1>WPQ44>TMM+)90W8KA: M;0Z3\[W4AO#_V*+N3K):#V6.&+B&C#;]@+%H=_?0PK>4Z$ "Y8L2JU;::1JI M:V%%B;_[[BN@0%$"T"HS#?.\E6[N8RY%\'GLL0K*%262])EJ>N!URXBU]]3? M^1J\@@UE6#VTT3#&;XH96X.!3--,;)[1>&;%/%(H7I3P+VBO8=1CR5G,#!.S M3_8.43'"JSE7Z:"048(]O[&&"=\KZEJ:VMON?!V7VV>@[J93W\@;TD.)H\1Z M]49QR8^TSJAZ*?^*5-!60 G[H*:;'F=HG-EA;]WM31[=CAG/*'.D@K)&"?E\ MIAIF^UD^*N+VZ8W7Z41R__:02B&4,$J %[#6,.2]>E3C/9! P:)$=I5VD,:$ MFU4\)V)&_:L7JI50P"B17L@.O2@1G\\4$MMB;;@]H^XFG,V( M?R=9, %XGPTF\8#5IO?OY5M^W YNE>;U&-H/U=@]4BAPG"V2(7M-H\X29FA2 M5&G(!!&Q#:FV^]H\T7E]*F@#X.RA!)I&>;S_C7+^4L+O M30)M!<0YQ!J[*$WP5?+,4E+Y0E#E.0<\4BARQ+E#CSV( MN"\%%#SB)&+8+-+Z-$-=G=DS?4\,V=0PQ-^7 LH?<4(Q;!9M_;P:V O/3(;G MS ^$4-J(2V$KK:% 'J>$\^M,,T%U<&PY$$(A(ZYYK;2& ODFI6IF![4/2B[- M?+.W,P3;DP *'7%E:] J#OS5CWWDQ?ZW(/D*-?CM!(C8O2:Q7KL1QVXA17$E M%PE1'NHA/90[ZL9*O]&&R=^9.56[]T]Y948V;@LM>JA/!6T%E' 5:AKGVKJS MDS]X:=W307DC!J95QG#V3&43SN(AER1X7[XG@_)%C$(K;*'@O2;B264+$Z_O ME8PI==,G>GNV 0(B8 ;0)D&,3U^$ N=Q@4Q3MYE(QD_CN36M[S*3O[G4UB_X MT""8#MHTF)LX <:1[H+TCXU>-+E>/] I56Z9PB-=F6M;T%/XI@B0'-H^J&\4 M F.H:*:+SI&O6WO O9NV^,;][=V],T8$DSHWEI M9B2KI_^9C0TR9<+FEOGVMV)>^8TP4[-T;MZ]_:W1:W8ZO_VGGCD=.= -NIKV MV^S(<2:U0N'AX2'_4,I;XJY0K%:KA1GVR7J=:K/$?JJB% M?+B]ZVHB-:8Z; MMD--C2T&&=R\3X>/K8NN V'P2%=\$B I%59 0ZN^'!#N?%CP&B-=G<2N%:^K M$W3EME56BT?KZ/!Z+ ;,TOH6D6:8(?ORKGNQ[.XD]U]V+3B"FO;0$F/J@ @1 M4B6GJ#GU, 0D9S,M @B^Y^^LZ:-PCG.E8@!G13C1F6+S@-H+CNLLQNX )S3 M"+44=!1LF KVL "M04?7SMU1.EET'E)[(#OZ#1&H\$Q8!K,3>\N62'?-3Z\PDP6O.^OV_4UGFC<0._D'B2 MRSUQ<.GH%F=XNYS9;3"SIP,I5Q>#GC&Z4KUEH%! .OQMC)FIPX]S9M"[VR$U M;/9,2&T31#!O BA!C8ZIL]E[-K]5X,_QL:I4*T\'>_@.&-RZ+=[ZGL"##X\V M *'>]D94,/M6O95^SX-ARV<;@&DA)3<^J-(*06FP!Y8^)[8S-]C;[! TKD:* MRL0A?3Z&'E?L@72M,34/O <'@%_P(2JVSJ?!,)W;$X/.:\2T3(9M?%9#)64" M-%]^X;K.3#0#_ :]KMPQP-$\%9\Y7?01#?MZB!J"[@ULAY@P28#->"TB^"SA M^MLLGTUSZK&2K4LU."U$P#X;4:)>A!&"22^UY&58$2@(3N4H%U@XCU8):>@Z MB,GN.=1AU^)&6%..:UZ]V4A"70@S&@D!W\H$K/;,ENWHP6NV7)J!("+7V]I( MNF>P<#T76&=^9NM9O]D!1_0V:_/QQ&#H?'PT$<@>*MMRA8\).DE=J_G3EU.- M3=]WB4%/)N<;/%P\YCHV##D31!+.$E>Y9N=]5"SQP0MDA21L/JX),-+25TB M.$,X+1! ?4E] &?9%A\%^IHR)FB)D13&'CSSV1=AJ6MRCY]@T7$FCAFU7<'J MON77H$L *FB*P$=8R< ])Y(&WY^\[/-,!$M/%4<";@4$M\)0'"F5G3J66+9N M//0DP0QA;S+3&W'P$YZ/\B"-- !LTAZDM+\TS>=[2G!1A;SV0R MIY--W?D)&5-QQ\T:P:[@5/_]S^*A"/?&52[)RI@MRV#ZR?$ M;PS@>.W%93M.+6?S'["JPM,E Y"E_K\AZ@L1\G?.\8%EZ*1XO!G,HWRY@J#E M1_AT0M"7Y*C![Z"'!BZ0"6#@H/[QJM-OMTBOW^BW>Z>%03U%["_"OXZ 7KOY ML=OI=]H]TKAJD?:7YN^-J_-VIGE]>=GI]3K75VNHVI#3(:K4_.$:HCY3>P0Y MLF,!N%:^F2>J4BE7MT?(#HP,21ML;FL @%#7L1:FI58>M:S79#DP[P!GFG!V M:T!GU]U+HZ%E1:QC',E@M*6JV?IQ['P\53PM(:OTGJ/)+5X%7HID[--LGZQAXR&[[ MJD^Z[9OK;G\G_G ] 8^9V*:(BT>'^:*/&3^74I#[S[B)P7R-Y)2\4D%A DDW MKK!=:CH9QP(,&I:U2+%$+$&*E3U]GUC#TX' G*4_8MC!%=SA0%][IHVH"7)N M: YT(L5JJ;Q5:]@!NYXLIQ:LXN3ZS%<4LA=\;S>Z%[#"]C/M3TL]:K?V:T@C MP;4CYL .8P[L1B8H;2][2?9D9TJS^/[XYF;*[C;R9%Y5$KV64],!^ACZCG0Z MGS.(J,TD3Q[F"=+5G7U9)Y,;MLVZ.Y_LQ5.PE76)7+V?IYYZ+=@-"\ MV6E?-=N] ]*Y:N9WKL\17Y,:(^^U9Q3\)\X'G:A8S"-#;6)/F(:5%YUP8+-C M$_"X H;M[\;B_G\,93?\<^C 8"!9PP!5TG!K,*MDY?<)U?7@^\8H0ZGZ(@/7 M+,.@$QL8&'S">K$C NA3)ARN42-0-Y"#7R$Z=?2@DP^X5'J38N'2O#>N:2M*_(^.GLK^\L[9'_7+9]Q@0.J B61> MCRJ]KY/Q>9_VZ(M\\A)/F&^'V;J2*U:/2L47LFWW6JM&V-:GLXY?"M>D=JSC M88N[]DCI2M5\NXT!U5JL=/Y"G\(S;W%UOD]IXT+4PR M+&?$!/D&686M.D&+(8\;(O[ZW1BFY0UK?&8VWC0@Z &DRLK_]-P=[H] MTAY/#&O.A,>&J/17B/$%69!+3_W5Q>!/CAS;$5/S-^S\7Q?<9,5D,VN6OK2+ M1J_TWYGQ(C-+0!@VL>-LO50JD8O&^W:OTVJ35K?SJ9UB:@_&A+=UZLW'1.;ON7G4:"^W??OKY,VL,>S[; M,.B?". 8GU"#L!G37(=/&;@_L'EFIT3Z7C+W+,*>79K:!6NB*#JPA&$W7@=+\^-O7ECO_<'GX3!T(XPA+O9BM'U:4%)GOI[K' M"PL"JIN19:Z-MJV/VN>[\Y9R.1L^D^PXGC#I:K9>.<+H4$FC?U?%U73U7=9J M_OW/8[5X=&)#/X--< 894T[A &,_P\60YL/*BFG&P)J1 3.L!P)3Q49D"#G. MO<\,N8$ZQFU0.(>9.K# L8 +8]=PJ,DLUS;FQ(;8VQ[.Y4A_@#4 %GLAN>6! M7%;NB MP@+WF/&@;6@8@QW%8>N"86]BU[3"VE#\*5*"2KX2+:<^%'M:@;ZX- MR8/%JSG9 ;I7=:^M26[U,_"^Z G#!'QME8%D&HZ8\'!EVN8EDA/UNR9/#\4FJUPW_(CX\H"L, MD$S\K3G422R"DK):\;7+B6[&X1[<7O&(-,^Z1"TI>>CH6^Y?2 DJOA+T+/"D M,&_S[A*L&TS<2-: H[NO^B=%GQQ]?/Y&6IH&K-(0%G]Y,_$O@0%+/6BKLB^6 M::ZHAL0?V8!="+^LY+V>?SWY!_6X&\'0\O#@K#RO@7Y;7 ^':2'6);OO]2>L M]\'9OAZDTQ+6A\IF^@! 8/]IVN'U_>OIQU&R?G1LVV7B M42UI?="_3(:'U_/!_:ZU9(6BL*X<[EI72BQ7WM.>IBM^WQ?I2B0.W&:DDJ9O M@M^-G,1SKX@UM&IZ,1L3$/6%V;0X!2--RAIFD$? FBV%;*]MVQ"KV:D; 1[K M5O<"/(#0'M_;#;9G*F^B^[Q*6G;2Q[>X,%)F5!L1#7(/.['.'MY17L'J-_J2 M3VL.]""5Z.*3B194)J>]^1@2QCVLT_TBDLMO N'LIEA_Y9],D-)A@:, ZW@8 M<6WD;5(L[0A5.K0QL5:U$O>87L@5O]U@PZ313Q)M0EDRR#Y\US$OJ@.IM7QQ/>'G 8CAX>!! S[&T^P,RH8),J>&R _(O):\H13+! M]WQ&CVU,I^OK!%7.G#PN@2 MA^_G?Q%S?TH]]F3W84^U[X+W M-/='9>O9T1IB0CY$539*C!:_=BK?GZ)$G>$:P\:MDIB7R$@OP5?JTB/P =+E M@@\P+9GJN#:3O4!\?O4;[[?@,OWQWJ5%"4I!9J:EBXHIJ\" +5&B\7T:G0;:_NK:?E6:4]NA^XD;#OR&_1$@+5V:9R["RG M30#\BU[^3(]E5EX._<6G>G^1%' &)S#NNXL5& OIR.CQ*65Y *1N]S P86#(1-)*%A7(<)J!!_*JXE6\,8PT)=RG/'2_GZ M&D^Z1WCD!%XPPQ>ZAU\^C^@,7G6%:=W1]"(W5W(DF0]U'#8&FU34U,1L;6;E MEZR]5[T89-".*V25H\4%+$J6L'%M:P*E%(+E:WD62]@GI&WX2U:XZPGN[5O< M=&3Y%5I6QV$TPTP;;RJ8DX80N,!A;SNI>WK*L[O*8U@/XGKRLJ#F\?5GK6JD MR"VSJBL*-[.%>L+S? 6U*&Z2V?J>[E7M4L[R+G#%I$L7DL][BB?%]+*T=+?O MP5V;Y(P-A$O%W(/LO])W0*@#TX%<7FX]^@'8.PLBMJ@M[,'S#![64943V2P_ M%T]DT'8NK[4B/8W+FVP./!0=4\O+<<0?YP?TP7%A3=D N\ZW\@3S5P<145BX7 MD \(&P[1HN$Y'X^9CJ=%#,B5AXZ?7FN&94MJ;%<;!9S*RU=A)80,Y#((V4?< M$GXVBZA7<#9X M[!#6#*C5"K_ OP)9Q&ECT@+['C M.UNR&!T=E7G -^@"R40F<2 A.I(H"C] E6 &Q7ZX%LR]+(AJW@X:-Z>6,47J M8N(=H?D(YI^4DK[4VU.3JU-9*4-:X_6WAIDNNW,-[\10+_<^_\J.52W 1:?X MP U#LH3C^61(,6&90M8!&QEJJA:L:S@M3!1!=S*H\["012Q--GKIZ)ARR:2E M%I?DG5DD&.?GG8@*4DFAXP657MZ9K'A>CHF7IN68]^[$TE%D(A1"%GHGZ-@. M'R^\P]381AT:,&"&SD+[HG%<0*9*VM]=#BH"#@[?S FW!@0HX4-#1\$EO5J M!=T@.K,UP2?A0VQR*BC@&-O0%,"W2RF&^9Q9^E\-1@[PJ!NP#V5GN8*TL.#( M/28):S8G\B4!:?E#6#7TI51#Q4-$OR@"A%[&V>NUF_NH5)=4:"./&VI)KF2E M#,>S4Z;I>ZQ499$7-T9=8-QE>LY=,@(+JHY#M9'O/TS"9B,^X-+C)(#/-%TA M<')=Z1"05CQHZ)%ZG'N_,NEVTYN/ORQ7Y&345ZPRFC59'&J,\W8B7V< /XI+ M.3#+!$W05KSF@E>+Y<7GI1\*1%G>]OCM#:]6\T6OMUR@D,4[8M6?.5]:ID?5 M/%Z7EY(>I65#9XLZWL)6 Y.4HO@[.WEEV8 MW![%ZL32X!L$[QCG>C^]43[^9^ST.SBIJ'XMH"Z M;EL@]3[-37<&O G@)3\-/$1^0'YGQI2A9(%R2&ES"?7IX(*PI^UGO]+=AM>F M$NFW=';.KQK]C]VU=X2^#N*#R^)DB))=W!,7!.P"+]L7RS)V-(W+))T!.4C: MD=9=8P[9H^O5_Q:AO9^1V\! :+"\^X\&;$2-85"#\DI'7@>LY;@FC)'@J.N, M+,%_,/WO:&%E(:TH*3>GK%E='QL*FAV_9Z%GOW:&+R/D)=%5$C4%NT!:#$;2$?D]3_K, (U_!5SZ533M])AV^]/- M 6GZU^6 TQT.*1< X9R9$((9!&^QLIFQO; ]F0RL%"RI@.5 , <"T=5CX7\7 M#791-,![/&M/*AM$4P0UN.-SYS6$O\!IBC51?NF$7,NTTJZ1"WR)_B\9]&\O M!']EDOTSSB#IQ%(!_S,B^5]<.6.C_C]02P,$% @ C()"6(7E!.)_" M>!T !4 !T;3(T-#DR,F0Q7V5X.3DM,2YH=&WE66MSVD@6_4X5_^&N4Y.: MJ0*,'\G&-G$-!FPS0XP+2&;S*=5(#>J)4"O=+3#[Z_?[CG'M;:EU.W@U.JY769:_=Q2?Q7VO2GPQZIZW=_!-W=XO;K;-A]R.- M)Q\'O;<[,YVX8]IKIHXF:B$M7CHJ+'7VCT[ M_7J)[?']=QVHQ;S;W&K^G\QUJ#R9O=W9N MEYJTSP8]ZO0&@^MVM]N_NGB[T]SQO\?7[4[YN]ANJDTH33W0<2Q2*X^I_'9" M*Q6ZB!W5_&''N[@U&973EM(X%8BX-':JG=.+G2(2K4FW'%@L\H;7*+TVZ7YS MW'[SAQ/* S35/_0;X-_JW07\7X>/39FN5YX3QBPB^ M9$KBIL7%?K*4UFECGQU7Z_VI*L!\,C(63NG$_CSW46P$>M':?7_Z["#_(C%L MVRB6$!+ZU0?QG0R5>'90"&":36,5?!*SF5#F#X*WZP7):].VT#UVORT)Q=#O MB.]_N. );:MV(!,GC=?J2:]+@^&''MS>K=$OP_[5F"[Z U04&G?ZO:M.;_S2 MV"^9/J&S87O4K5:&Y]3MCWJ=R7 TIH?E_;\(\H2F(O@\-SI+0A9P;8YI%2DG M/?I6?^.H_ND38OD]LT[-UM\'M3)V)@M< M9B1-(FE$*C/(GFW0M9%+I3,;KQ%Z22M$GU?&9:M"6.%W[41*SJAW(P/,@I'# MV4P%TAMV$>NIB.DLUCJ\LW21@"MU*Y M4.'Z2PDB(W\H0E).\Q2C0!C)^SNZD E+8A U:).]\$.".&%"M?*NFX>(T^&C M@'O'0:1US&BYI 8JD1XG!R66K!.""IC!FE0"$!#-:NPTDU$ BWSSEZ#<5QTHLJ,>DT%F(99!>.6JZ"1+M.0IXY3A?5*H;S$'WK=60#:^=F'\6P[DHI$6ZP=#_^7)5[/EB?V__U?X1NHKSX=5D MXVDOC5R,K%-05 MU4Q"2HL>HBO6M5L9_$ZEJ5:XU-SM5%'->GTACQ]4Z-N M.5#6J(9WD<]F[J@$2IL!8\@R>D1'!5O)4?.VLTQO2EK!;+ZNDB#.K.\ .+Z6 M@'D& QF+-RAW3-F7T5+$&;N' :Q ?50![,]7Q10L!(65Y\1#H0/4%=L B$GF MHPL7,0B=&5*P+'",+@6K8(8M"X!G,DB?I_5*FSA

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tm244922d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000882095 2024-02-01 2024-02-01 iso4217:USD shares iso4217:USD shares false 0000882095 CA 8-K 2024-02-01 GILEAD SCIENCES, INC. DE 0-19731 94-3047598 333 LAKESIDE DRIVE FOSTER CITY 94404 650 574-3000 false false false false Common Stock, par value, $0.001 per share GILD NASDAQ false